category,datetime,headline,id,image,related,source,summary,url
company,1768040125,Humana (HUM) Valuation Check After Mixed Shareholder Returns And New Discount To Analyst Targets,138069458,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,HUM,Yahoo,"Humana (HUM) has been drawing fresh attention as investors reassess the health insurer’s recent share performance, with the stock showing mixed returns over the past year and over longer multiyear periods. See our latest analysis for Humana. Humana’s recent momentum has picked up, with a 7-day share price return of 4.68% and a 30-day share price return of 7.87%. However, the 3-year total shareholder return of 41.78% and 5-year total shareholder return of 28.76% remain weak. If Humana’s mixed...",https://finnhub.io/api/news?id=90a84a20e6607f8d5bb2aa46b71955660dd90f7b0d26d19b18f9992446d77323
company,1768032504,How Recent Margin Concerns Are Shaping Humana’s (HUM) Evolving Valuation Story,138069459,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,HUM,Yahoo,"Humana's fair value estimate has been nudged from about US$288.46 to roughly US$287.38 per share, reflecting a more cautious stance around how quickly its government managed care businesses might settle into a steadier earnings rhythm. While the discount rate remains essentially unchanged at about 6.96% and revenue growth expectations are now around 9.65%, the mix of bullish and bearish views on Medicare Advantage and Medicaid is keeping opinions split on where the stock should trade. Stay...",https://finnhub.io/api/news?id=b12bd1ac431f28b62dbdfc3edebc85a52439f777960e24dbde8a5892a2fff539
